Skip Nav Destination
1-20 of 24
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Posttransplant Lymphoproliferative Disorders in Pediatric Solid Organ Recipients: A Multicenter Retrospective Analysis of Patients from 1990 to 2003.
B. Maecker, T. Jack, H. Abdul-Khaliq, M. Burdelski, J. Ehrich, A. Fuchs, M. Holder, B. Hoppe, P. Hoyer, A. Karow, S. Koepf, U. Kraemer, T. Lang, G.F. Laube, A. Lehnhardt, E. Maass, D. Mueller-Wiefel, H. Netz, M. Pohl, B. Toenshoff, M. Wallot, M. Zimmering, K. Welte, A. Reiter, M. Melter, G. Offner, C. Klein
Blood (2005) 106 (11): 1929.
Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation
C. Zeidler, K. Welte, Y. Barak, F. Barriga, A. A. Bolyard, L. Boxer, G. Cornu, M. J. Cowan, D. C. Dale, T. Flood, M. Freedman, H. Gadner, H. Mandel, R. J. O'Reilly, U. Ramenghi, A. Reiter, R. Skinner, C. Vermylen, J. E. Levine
Blood (2000) 95 (4): 1195–1198.
Clinical Relevance of Point Mutations in the Cytoplasmic Domain of the Granulocyte Colony-Stimulating Factor Receptor Gene in Patients With Severe Congenital Neutropenia
N. Tidow, C. Pilz, B. Teichmann, A. Müller-Brechlin, M. Germeshausen, B. Kasper, P. Rauprich, K.-W. Sykora, K. Welte
Blood (1997) 89 (7): 2369–2375.
Blood (1996) 88 (6): 1907–1929.
A randomized phase-III study of the efficacy of granulocyte colony- stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Munster Study Group
Blood (1996) 87 (8): 3143–3150.
The protein tyrosine kinase JAK2 is activated in neutrophils from patients with severe congenital neutropenia
Blood (1995) 86 (12): 4500–4505.
Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt's lymphoma cells
Blood (1995) 86 (4): 1469–1480.
Differential regulation of stem cell factor mRNA expression in human endothelial cells by bacterial pathogens: an in vitro model of inflammation
Blood (1994) 83 (10): 2836–2843.
Severe congenital neutropenia: abnormal growth and differentiation of myeloid progenitors to granulocyte colony-stimulating factor (G-CSF) but normal response to G-CSF plus stem cell factor
Blood (1993) 82 (10): 2991–2997.
In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates [see comments]
Blood (1992) 80 (11): 2740–2745.
Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors
Blood (1992) 80 (5): 1199–1206.
Expression of receptors for granulocyte colony-stimulating factor on neutrophils from patients with severe congenital neutropenia and cyclic neutropenia
Blood (1992) 79 (5): 1144–1147.
Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia
Blood (1991) 77 (9): 1919–1922.
Blood mononuclear cells from patients with severe congenital neutropenia are capable of producing granulocyte colony-stimulating factor
Blood (1991) 77 (6): 1234–1237.
Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia
Blood (1990) 75 (5): 1056–1063.
Blood (1988) 72 (5): 1456–1460.
Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow
Blood (1987) 70 (6): 1893–1903.
Interleukin-2 production and response to interleukin-2 by peripheral blood mononuclear cells from patients after bone marrow transplantation: II. Patients receiving soybean lectin-separated and T cell-depleted bone marrow
Blood (1987) 70 (5): 1595–1603.
Blood (1987) 69 (5): 1508–1523.
Constitutive production of leukemia differentiation, colony- stimulating, erythroid burst-promoting, and pluripoietic factors by a human hepatoma cell line: characterization of the leukemia differentiation factor
Blood (1985) 66 (2): 407–415.